Um unseren Shop in vollem Umfang nutzen zu können, empfehlen wir Ihnen Javascript in Ihrem Browser zu aktivieren.

Structure of HCV NS3 1406-1415 (A*02:01)

Infectious disease

HCV NS3 1406-1415 (A*02:01) KLSGLGLNAV

Product number: EP08800_5

€ 126.80 *

Prices excl. VAT plus shipping costs

Available, delivery time: 3-4 weeks

sterile and endotoxin free

Delivery Format: The product is supplied freeze dried.

Purity: 95% HPLC-MS

Caution: For research use only. Not for use in humans.

Amount in mg

1

Add to Cart

Description

The HCV NS3 1406-1415 (A*02:01) peptide with the amino acid sequence KLSGLGLNAV is a linear peptidic epitope (epitope ID 32167) studied as part of Genome polyprotein (UniProt:P27958) from Hepatitis C virus.

HCV NS3 1406-1415 (A*02:01) has been studied for immune reactivity in publications and has been tested in T cell assays and MHC ligand assays.

TechData

Sequence:	KLSGLGLNAV
Delivery:	3-4 weeks
C-Terminus:	OH
N-Terminus:	H
Amount:	5 mg
Counterion:	TFA
Protein:	Genome polyprotein
Species:	Hepatitis C virus (HCV)
Allele:	HLA-A*02:01
Application:	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication:	Infectious disease
Purity:	95% HPLC-MS

Documents

Storage and handling of peptides

Probing of membranes with HRP

More HCV peptides

HCV (gt. 1b, isol. BK) NS3 1406-1415 (HLA-A*02:01)

HCV (gt. 1b, isol. BK) NS3 1406-1415 (HLA-A*02:01)

This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed NS3-derived peptide of KLSGLGINAV sequence covering 1406-1415 and A*02:01 molecule.

Ab 105,00 €*

HCV core 111-119 (HLA-B*07:02)

HCV core 111-119 (HLA-B*07:02)

DPRRRSRNL is a linear peptidic epitope (epitope ID9746) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity and tested in T cell assays

Ab 105,00 €*

HCV core 132-140 (HLA-A*02:01)

HCV core 132-140 (HLA-A*02:01)

DLMGYIPAV is a linear peptidic epitope (epitope ID9199) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV core 132-140 mutant (HLA-A*02:01) 139L

HCV core 132-140 mutant (HLA-A*02:01) 139L

DLMGYIPLV is a linear peptidic epitope (epitope ID9203) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays

Ab 105,00 €*

HCV core 35-44 (HLA-A*02:01)

HCV core 35-44 (HLA-A*02:01)

YLLPRRGPRL is a linear peptidic epitope (epitope ID74798) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays

Ab 105,00 €*

HCV core 41-49 (HLA-B*07:02)

HCV core 41-49 (HLA-B*07:02)

This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed Core-derived peptide of GPRLGVRAT sequence covering 41-49 and B*07:02 molecule.

Ab 105,00 €*

HCV E1 207-214 (HLA-B*35:01)

HCV E1 207-214 (HLA-B*35:01)

This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed E1-derived peptide of CPNSSIVY sequence covering 207-214 and B*35:01 molecule.

Ab 105,00 €*

HCV NS3 1031-1039 (HLA-A*24:02)

HCV NS3 1031-1039 (HLA-A*24:02)

AYSQQTRGL is a linear peptidic epitope (epitope ID5934) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assay and MHC ligand assay

Ab 105,00 €*

HCV NS3 1073-1081 mutant (HLA-A*02:01) 1074V

HCV NS3 1073-1081 mutant (HLA-A*02:01) 1074V

CVNGVCWTV is a linear peptidic epitope (epitope ID7292) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV NS3 1359-1367 (HLA-B*35:01)

HCV NS3 1359-1367 (HLA-B*35:01)

HPNIEEVAL is a linear peptidic epitope (epitope ID24479) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV NS3 1406-1415 (HLA-A*02:01)

HCV NS3 1406-1415 (HLA-A*02:01)

KLVALGINAV is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. Single peptide (KLVALGINAV) for stimulation of human HCV NS3 (1406-1415)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.

Ab 105,00 €*

HCV NS3 1436-1444 (HLA-A*01:01)

HCV NS3 1436-1444 (HLA-A*01:01)

ATDALMTGF is a linear peptidic epitope (epitope ID4916) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y

HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y

ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV NS4b 1807-1816 (HLA-A*02:01)

HCV NS4b 1807-1816 (HLA-A*02:01)

LLFNILGGWV is a linear peptidic epitope (epitope ID37286) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assay and MHC ligand assays

Ab 105,00 €*

HCV NS5a 1992-2200 (HLA-A*02:01)

HCV NS5a 1992-2200 (HLA-A*02:01)

VLSDFKTWL is a linear peptidic epitope (epitope ID69751) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV NS5a 2266-2275 (HLA-B*40:01)

HCV NS5a 2266-2275 (HLA-B*40:01)

REISVPAEIL is a linear peptidic epitope (epitope ID53541) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays

Ab 105,00 €*

HCV NS5B 2588-2596 (HLA-A*03:01)

HCV NS5B 2588-2596 (HLA-A*03:01)

RVCEKMALY is a linear peptidic epitope (epitope ID56247) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Ab 105,00 €*

HCV NS5B 2594-2602 (HLA-A*02:01)

HCV NS5B 2594-2602 (HLA-A*02:01)

ALYDVVTKL is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus.

Ab 105,00 €*

HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S

HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S

The HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S peptide with the amino acid sequence ALYDVVSKL is a linear peptidic epitope (epitope ID 3017) studied as part of Genome polyprotein (UniProt:P27958) from Hepatitis C virus.HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S has been studied for immune reactivity in publications and has been tested in T cell assays and MHC ligand assay.

Ab 105,00 €*

HCV NS5B 2727-2735 (HLA-A*02:01)

HCV NS5B 2727-2735 (HLA-A*02:01)

The HCV NS5B 2727-2735 (HLA-A*02:01) peptide with the amino acid sequence GLQDCTMLV is a linear peptidic epitope (epitope ID 21079) studied as part of Genome polyprotein (UniProt:P27958) from Hepatitis C virus.HCV NS5B 2727-2735 (HLA-A*02:01) has been studied for immune reactivity in publications and has been tested in T cell assays, B cell assay and MHC ligand assays.

Ab 105,00 €*